Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2000
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2372234A1 Oxazaheterocycles as protease inhibitors
12/06/2000EP1057490A2 Use of tranexamic acid for the preparation of a human fibrinogen composition
12/06/2000EP1056854A2 Protease-activated receptor 4 and uses thereof
12/06/2000EP1056839A1 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
12/06/2000EP1056779A1 Method for producing a factor viii/von willebrand factor complex
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056749A1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS
12/06/2000EP1056743A1 Benzamine derivatives
12/06/2000EP1056449A2 20-hete antagonists and agonists
12/06/2000CN1275981A Novel pharmaceutically active compounds, their preparation and use as ECE-inhibitors
12/06/2000CN1275916A Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
12/06/2000CN1275886A Method for lowering platelet counts
12/05/2000US6156756 Anticoagulants
12/05/2000US6156734 Cardiovascular disorders
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156321 Tissue factor methods and compositions for coagulation and tumor treatment
11/2000
11/30/2000WO2000071736A1 Isoflavonoid methylation enzyme
11/30/2000WO2000071713A1 Vascular endothelial growth factor variants
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071516A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071515A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071507A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071493A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071153A2 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071141A1 Modified factor viii
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071112A1 Therapeutic uses for nitric oxide inhibitors
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000CA2382751A1 Inhibitors of factor xa
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374947A1 Inhibitors of factor xa
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374820A1 Inhibitors of factor xa
11/30/2000CA2374793A1 Inhibitors of factor xa
11/30/2000CA2374788A1 Inhibitors of factor xa
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374650A1 Inhibitors of factor xa
11/30/2000CA2374646A1 Inhibitors of factor xa
11/30/2000CA2374641A1 Inhibitors of factor xa
11/30/2000CA2373822A1 Vascular endothelial growth factor variants
11/30/2000CA2373751A1 Isoflavonoid methylation enzyme
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2371904A1 Inhibitors of factor xa
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054913A2 Method for the production of polymers from n-vinyl compounds
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054892A1 Azole peptidomimetics as thrombin receptor antagonists
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000CN1274723A Dicyclic compound, medicine composition containing the same and use thereof
11/29/2000CN1274722A Compound capable of inhibiting thrombocyte agglutination and resisting thrombosis and its preparation and application
11/29/2000CN1274588A Composite thrombolytic medicine
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153588 Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-4-yl)butanoyl)-N-ethylglycyl] aspartyl]-L-β-cyclohexyl alanine amide
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000CA2172149C Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069839A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069833A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
11/23/2000WO2000069832A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants
11/23/2000WO2000069827A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069826A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069822A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069466A1 Trapping agent for blood carbonyl compounds
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 671